SG/CALL/ZOETIS/190/0.1/20.12.24 Share Price

Warrant

DE000SU2YLA6

Market Closed - Boerse Frankfurt Warrants 01:18:34 06/07/2024 am IST
0.98 EUR +1.03% Intraday chart for SG/CALL/ZOETIS/190/0.1/20.12.24
Current month+1.02%
1 month-14.66%
Date Price Change
05/24/05 0.99 +2.06%
04/24/04 0.97 -2.02%
03/24/03 0.99 +1.02%
02/24/02 0.98 +7.69%
01/24/01 0.91 -7.14%

Real-time Boerse Frankfurt Warrants

Last update July 06, 2024 at 01:18 am IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ZOETIS INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SU2YLA
ISINDE000SU2YLA6
Date issued 29/11/2023
Strike 190 $
Maturity 20/12/2024 (167 Days)
Parity 10 : 1
Emission price 1.89
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 3.16
Lowest since issue 0.35
Delta0.43x
Omega 7.067
Premium14.64x
Gearing16.55x
Moneyness 0.9208
Difference Strike 15.04 $
Difference Strike %+7.92%
Spread 0.01
Spread %1.02%
Theoretical value 0.9650
Implied Volatility 31.78 %
Total Loss Probability 65.44 %
Intrinsic value 0.000000
Present value 0.9650
Break even 200.46 €
Theta-0.03x
Vega0.04x
Rho0.03x

Company Profile

Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%); - livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%); - other (1.1%). Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%). At the end of 2022, the group has 29 production sites worldwide. The United States accounts for 53.4% of net sales.
Sector
-
More about the company

Ratings for Zoetis Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Zoetis Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
175 USD
Average target price
210.2 USD
Spread / Average Target
+20.11%
Consensus